[
  {
    "ts": null,
    "headline": "Medtronic Breaks Out On Another 'Clean Beat' And 300% Growth For One Segment",
    "summary": "Medtronic stock jumped and broke out Tuesday on a \"clean beat\" driven mainly by its pulsed field ablation technology.",
    "url": "https://finnhub.io/api/news?id=26613656d87bc609a6a5263340e3ea9f6027b4baadf963ec6038b4403e210ab6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763478025,
      "headline": "Medtronic Breaks Out On Another 'Clean Beat' And 300% Growth For One Segment",
      "id": 137538358,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Medtronic stock jumped and broke out Tuesday on a \"clean beat\" driven mainly by its pulsed field ablation technology.",
      "url": "https://finnhub.io/api/news?id=26613656d87bc609a6a5263340e3ea9f6027b4baadf963ec6038b4403e210ab6"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic Stock Rises After Earnings. What Caught Investors’ Attention.",
    "summary": "Medtronic  posted fiscal second-quarter earnings and revenue that broadly beat analysts’ expectations and the company hiked its fiscal 2026 guidance.  The medical technology company reported adjusted earnings of $1.36 a share, topping Wall Street’s calls for $1.31, while sales of $8.96 billion beat the $8.87 billion consensus among analysts polled by FactSet.  The company recorded its strongest cardiovascular revenue growth in over a decade, excluding the pandemic.",
    "url": "https://finnhub.io/api/news?id=27296a47541ebd5340dd604687badfe8048befa679eefcf08e4d3882cf3d3e68",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763467260,
      "headline": "Medtronic Stock Rises After Earnings. What Caught Investors’ Attention.",
      "id": 137538360,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Medtronic  posted fiscal second-quarter earnings and revenue that broadly beat analysts’ expectations and the company hiked its fiscal 2026 guidance.  The medical technology company reported adjusted earnings of $1.36 a share, topping Wall Street’s calls for $1.31, while sales of $8.96 billion beat the $8.87 billion consensus among analysts polled by FactSet.  The company recorded its strongest cardiovascular revenue growth in over a decade, excluding the pandemic.",
      "url": "https://finnhub.io/api/news?id=27296a47541ebd5340dd604687badfe8048befa679eefcf08e4d3882cf3d3e68"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Corporation (BSX) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript",
    "summary": "Boston Scientific Corporation (BSX) 7th Annual Wolfe Research Healthcare Conference November 18, 2025 8:00 AM ESTCompany ParticipantsKen Stein - Senior VP...",
    "url": "https://finnhub.io/api/news?id=5c02e7f00d1e3177a9c4c1db912c6b39d11b9bbccec54b67c39527c303b30feb",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763466533,
      "headline": "Boston Scientific Corporation (BSX) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript",
      "id": 137539269,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "Boston Scientific Corporation (BSX) 7th Annual Wolfe Research Healthcare Conference November 18, 2025 8:00 AM ESTCompany ParticipantsKen Stein - Senior VP...",
      "url": "https://finnhub.io/api/news?id=5c02e7f00d1e3177a9c4c1db912c6b39d11b9bbccec54b67c39527c303b30feb"
    }
  },
  {
    "ts": null,
    "headline": "Zacks Industry Outlook Highlights Boston Scientific, Insulet, BioLife Solutions and Allurion",
    "summary": "Boston Scientific, Insulet, BioLife Solutions and Allurion push ahead with innovation and efficiency as the Medical Products industry faces pressure.",
    "url": "https://finnhub.io/api/news?id=305f5b900cb180478a2e9b17fad1d3636a35babc2bf834e50d707b88f2102929",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763456460,
      "headline": "Zacks Industry Outlook Highlights Boston Scientific, Insulet, BioLife Solutions and Allurion",
      "id": 137538361,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific, Insulet, BioLife Solutions and Allurion push ahead with innovation and efficiency as the Medical Products industry faces pressure.",
      "url": "https://finnhub.io/api/news?id=305f5b900cb180478a2e9b17fad1d3636a35babc2bf834e50d707b88f2102929"
    }
  }
]